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The  promoter  of the major histocompatibility class 
I1  gene  DRA  contains  an  octamer  element 
(ATTTGCAT) that is required for efficient DRA 
expression in B cells. Several DNA-binding proteins 
are known to bind this sequence. The best character- 
ized are the  B cell-specific OTF-2  and the ubiquitous 
OTF- 1. This report directly demonstrates that OTF-2 
but  not  OTF-1 regulates the DRA gene. In  vitro tran- 
scription analysis using protein fractions enriched for 
the octamer-binding protein OTF-2 demonstrate  a  pos- 
itive functional role for OTF-2 in DRA gene transcrip- 
tion, In contrast, OTF- 1-enriched protein fractions did 
not affect DRA gene transcription although it function- 
ally enhanced the transcription of another gene. Re- 
combinant  OTF-2 protein produced by in  vitro tran- 
scription/translation could also enhance DRA gene 
transcription in  vitro.  In  vivo transient transfection 
studies utilizing an OTF-2 expression vector resulted 
in similar findings: that OTF-2 protein enhanced DRA 
gene transcription, and that this effect requires an 
intact octamer element. Together these results consti- 
tute the first direct evidence of a positive role for the 
lymphoid-specific octamer-binding factor in DRA gene 
transcription. 
Major histocompatibility (MHC)’ class I1 proteins  control 
the level of the immune response by functioning as ligands 
for the activation of antigen-specific T lymphocytes (1, 2). In 
addition, class 11 proteins  transmit signals which activate  B 
lymphocytes (3). MHC class I1 protein expression is limited 
to a few cell types, most notably on  B cells, and  is subject to 
transcriptional gene regulation. The transcriptional regula- 
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tion of class I1 expression is mainly mediated by elements in 
their promoters, presumably via proteins that bind to these 
elements. Several cis-acting elements critical for MHC class 
I1 expression have been defined in  B lymphocytes and  other 
cell types including the W, X, and Y elements (4). Further- 
more, the class I1 DRA promoter contains an octamer ele- 
ment,  ATTTGCAT, that is required for its efficient expres- 
sion in B cells (5, 6) (see Fig. 1A). This octamer element is 
identical to  the octamer elements important for the expression 
of a variety of other genes including the immunoglobulin (Ig) 
light and heavy chains (7, 8),  the human histone H2B (9), 
and the U1, U2, and U4 snRNA genes (10). The octamer 
element has therefore been determined to be a functional 
element for genes expressed in restricted cell types as well as 
for genes expressed ubiquitously. 
Nuclear proteins have been defined that bind specifically 
to  the octamer element. These include both the ubiquitous 
protein OTF-1 (also referred to as oct-1, NF-AI, OBP100, 
NFIII,  and oct-B3) (11-17) and  OTF-2, classically referred to 
as a lymphoid-restricted protein (also referred to as oct-2, 
NF-AB, oct-SA, and  oct-B2) (13, 14,16,18,19).  Oct-3 through 
oct-7 have been identified in various mouse tissues at different 
stages of development (20,21),  and related proteins have been 
identified in  adult  brain (22). Since oct-3  through oct-7 are 
not  present in the cell types used in  this study, they will not 
be discussed further. 
Both the  OTF-1 and  OTF-2  proteins bind to  the octamer 
element with identical methylation interference and DNase I 
footprinting  patterns  (11,19).  Both  proteins have been puri- 
fied from cells (11,19)  and  the corresponding genes  have been 
isolated (17, 23-27). Because of its  restricted  tissue distribu- 
tion, OTF-2 was hypothesized to be at least partially respon- 
sible for the restricted cell type expression of the Ig gene (16, 
18, 19) and  the MHC class I1 gene, DRA (5). In fact, it has 
been shown that purified OTF-2 can activate  transcription of 
Ig heavy and light chain promoters i n  vitro (19,28,29).  It was 
also demonstrated that  OTF-1 could activate  transcription of 
these same Ig promoters in vitro, but less efficiently (28, 29). 
The difference in OTF-2’s versus OTF-1’s ability to activate 
transcription from these two promoters has been suggested to 
be due to the requirement for an additional B-cell-specific 
component (29, 30) or due to quantitative differences in the 
amount of octamer-binding protein  present (28). The context 
of the octamer element within the promoter may also be 
important (28). It has been hypothesized that the B cell- 
specific octamer-binding protein, OTF-2, is required for MHC 
class 11 DRA promoter function in B cells, but  this  has yet to 
be shown directly. 
In this report, we demonstrate a functional role for the 
octamer-binding protein OTF-2 in MHC class I1  gene expres- 
sion using both i n  vitro transcription  and i n  vivo transient 
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transfection systems. This  is  similar  to  the positive functional 
role for OTF-2 observed in  Ig gene transcription (19,  28, 29). 
In  contrast  to  the Ig system, however, OTF-1  appears  not  to 
play a role in transcription from the MHC class I1 DRA 
promoter  in a B cell system,  whereas it can  activate  transcrip- 
tion of the  testis H2A histone (TH2A) gene in  our system. 
These findings underscore  that even though  there  are several 
similarities between the  Ig  and  the DRA genes, including  their 
expression in B lymphocytes, there  are  significant differences 
in  their  transcriptional regulation. The differences  observed 
may be due  to  the  context of the octamer element in the 
promoters of these genes. The octamer  element  upstream of 
a TATA box seems sufficient to  confer B cell-specific pro- 
moter activity of Ig genes (31, 32), whereas MHC class I1 
genes require additional promoter elements for expression 
(33, 34). 
MATERIALS AND METHODS 
Plasmids, Probes, and Competitors-The construction of plasmids 
pWToct  and pMUToct (Fig. lA) have been described in  detail  (5). 
They contain wild type DRA X and Y elements and either  a wild 
type or mutant octamer element placed upstream of the bacterial 
chloramphenicol acetyltransferase (CAT) gene. 
The human OTF-2 cDNA  was isolated by polymerase chain reac- 
tion-based cloning from a human B lymphoblastoid cell line, Raji, 
using published DNA sequences (26). First  strand cDNA  was synthe- 
sized by avian myeloblastosis virus reverse transcriptase (Life Sci- 
ences Biologicals, St. Petersburg, FL) from 2 pg  of oligo(dT) (Boeh- 
ringer Mannheim Biochemicals, Indianapolis, IN; 10-mer) primed 
mRNA isolated by batch elution (35) from lo8 log phase Raji cells. 
Five percent of the reaction mixture was subjected to 35 cycles of 
amplification by polymerase chain reaction in  a DNA thermal cycler 
(Perkin-Elmer  Cetus Corp., Emeryville, CA) using 50 PM each kinased 
primers of the sequence 5'-ACGATGGTTCACTCCAGCATGG-3' 
and 5'-CTGCCATCAGGCTGGTAAGG-3' (26). The temperature 
profile of amplification was  94 "C, 5 min, 55 "C, 1 min, 72 "C, 1 min 
for 1 cycle; 94 "C, 30 s, 55 "C, 30 s, 72 "C, 1 min for  30  cycles; and 
94 "C, 30 s, 55 "C, 30 s, 72 "C, 7 min for 1 cycle. Products were 
separated on a 2% Nuseive low melt-agarose gel (Seakem, FMC Corp., 
Rockland, ME).  Three microliters of remelted agarose containing the 
1.4-kb DNA band predicted for OTF-2 was directly ligated to de- 
phosphorylated SmaI-digested pGEM3Z (Promega, Madison, WI). 
Sequence of the resulting clone determined by dideoxy chain  termi- 
nation (36) was identical to  the published sequence (26). 
To obtain the OTF-2 expression vector, human OTF-2 cDNA 
cloned into pGEM3Z (described above) was digested with KpnI and 
XbaI in the polylinker region to release the 1.4-kb OTF-2 cDNA, 
which was isolated electrophoretically and  then electroeluted from 
the gel. The OTF-2 cDNA  was then subcloned into the compatible 
cloning site of the plasmid pCMV5 (37). pCMV5  was a gift from D. 
W. Russell (University of Texas Southwestern Medical Center) and 
contains  the human cytomegalovirus early promoter (CMV), a linker 
containing multiple cloning sites, and transcription  termination and 
polyadenylation signals from human growth hormone (Fig. 1B). Li- 
gation was performed at room temperature for 4  h in a 20-pl  volume. 
The reaction was stopped by adding 1 pl of 0.5 M EDTA, pH 8.0. 
Southern and sequencing analyses revealed that  the 1.4-kb OTF-2 
was properly subcloned into pCMV5. This clone was named plasmid 
The DNA probes and competitors used for gel mobility shift assays 
consisted of complementary oligonucleotides that were resuspended 
in annealing buffer (38), boiled 5 min, and allowed to cool  slowly to 
room temperature to anneal. Probes were radiolabeled using T4 
polynucleotide kinase (U. S. Biochemicals, Cleveland, OH) and [y- 
:'2P]ATP prior to annealing and purification on a  NENsorb column 
(Du Pont-New England Nuclear, Boston, MA). The sequence of 
strand 1 of WToct is: 5"AGAGTAATTGATTTGCATTTTAA- 
TGGTCAG-3'. The sequence of strand 1 of MUToct is:  AGAGTAA- 
TTGCGGGTCATTTTAATGGTCAC"', where the mutated  se- 
quence is underlined. 
Preparation of Nuclear Extracts and Octamer-binding Protein 
(OBP) Enrichment-Nuclear extracts were prepared using a modifi- 
cation (39) of the Dignam procedure (40). 2 Liters of  log phase cells 
were pelleted, washed twice in cold phosphate-buffered saline, and 
pCMV5-OTF-2. 
resuspended in 5 packed cell  volumes of Buffer A (10 mM Hepes, pH 
EGTA, 1 mM DTT, 10 mM KCl). Cells were  allowed to swell 5 min 
7.9,  0.75 mM spermidine, 0.15 mM spermine, 0.1 mM EDTA, 0.1 mM 
on ice, pelleted, and resuspended in 2 packed cell  volumes of Buffer 
A. Cells were lysed using the B pestle of a Dounce homogenizer until 
95% lysis had occurred as determined by trypan blue dye exclusion. 
Nuclei were separated by quick centrifugation at 16,000 rpm in a 
Beckman SS34 rotor for 30 s. The pellet was resuspended in 1 ml of 
Buffer C/109 cells (20 mM Hepes, pH 7.9,  0.75 mM spermidine, 0.15 
mM spermine, 0.2 mM EDTA, 2 mM EGTA, 2 mM DTT, 20% glycerol, 
0.1 mM lJ0-phenanthroline, 0.1 mM 3,4-dichloroisocoumarin, 0.02 
mM E-64). NaCl was then added to a final concentration of 0.4 M 
while vortexing the extract. The nuclei were agitated 20 min at  4 'C 
and  the extract centrifuged at 150,000 X g for 90 min. The extract 
was dialyzed 2 X 90 min against 100 volumes of Buffer D (20 mM 
Hepes, pH 7.9, 17% glycerol, 100 mM KCl, 0.2 mM EDTA, 0.2 mM 
EGTA, 2 mM DTT, 12.5 mM MgCl2, 2 p~ 1,lO-phenanthroline, 2 p~ 
3,4-dichloroisocoumarin, 0.4 pM E-64). Extracts were then centri- 
fuged 20 min at 16,000 rpm in a Beckman SS34 rotor and the 
supernatant stored in small aliquots at -70 "C. Extracts were not 
freeze/thawed more than two times for use in in vitro transcription 
reactions. Protein  concentrations were determined using the Bio-Rad 
protein assay (Richmond, CA). 
Octamer-binding proteins were enriched by incubating 1 ml of 
nuclear extract with 1 ml of octamer-conjugated Sepharose affinity 
matrix. The affinity matrix was prepared according to  the method of 
Kadonaga and  Tjian (41) using concatamers of the double stranded 
oligonucleotides; 5"GATCAGAGTAATTGATTTGCATTTTAA- 
TGGTC-3'  and 3"TCTCATTAACTAAACGTAAAATTACCAGC- 
TAG-5', to couple to  the matrix. Extract was incubated with affinity 
matrix and rotated end-over-end for 1 h at 4 "C. Octamer-binding 
proteins were eluted with 200 pl of AClOOO buffer (Buffer D with 1 
M KC1) and dialyzed against 100 volumes of Buffer D using a  BRL 
microdialyzer (Gaithersburg, MD). Extracts were checked for com- 
plete depletion of octamer-binding proteins by gel mobility shift 
assay. 
In  Vitro TranscriptionlTranslation of Recombinant OTF-2 Pro- 
tein-In vitro transcription/translation of recombinant OTF-2 was 
performed as described by the manufacturer of the kit (Promega, 
Madison, WI). For transcription, 20 p1 of 5 X transcription buffer, 10 
p1 of 100 mM DTT, 100 units of RNasin, 20 p1 of 2.5 mM each of 
ATP, GTP,  CTP, and UTP, 2 p1 of plasmid linearized with either 
BamHI or EcoRI (3 pg), 50 units of SP6 or T7 polymerase, and Hz0 
to a 100-pl final volume were incubated at  37 "C for 90 min. The 
DNA template was  removed  following transcription by adding RQ1 
RNase-free DNase to a  concentration of 1 unitlpg of DNA, incubating 
for 30 min at 37 "C, extracting sequentially with pheno1:cbloroform 
and chloroform, and precipitating the RNA with ethanol. RNA  was 
resuspended in HzO and stored at -70  "C. For in vitro translation of 
OTF-2 protein, 35 pl of nuclease-treated rabbit reticulocyte lysate 
(Promega, Madison, WI),  7 pl of H10, 1 pl of RNasin ribonuclease 
inhibitor (at 40 units/pl), 1 pl of 1 mM amino acid mixture (minus 
methionine), 2 pg  of RNA substrate in Hz0  that had been heated at 
67  "C for 10 min and immediately cooled on ice to decrease secondary 
structure, and 4 p1 of [35S]methionine (1200 Ci/mmol) at 10 mCi/ml 
(Du Pont-New England Nuclear) or 4 pl of unlabeled methionine 
were  mixed in a final volume of 50 p1 and incubated at 30 "C for 60 
min. Translation products were analyzed on 10% SDS-polyacryl- 
amide gels and by  gel mobility shift assay, and were stored at  -70 "C. 
Translation products were chromatographed on Sephadex G-25 or  G- 
10 prior to use to reconstitute  in vitro transcription reactions. 
Gel Mobility Shift and in Vitro  Transcription-Gel mobility shift 
reactions were performed essentially as described (15). DNA binding 
was allowed to proceed for 30 min at room temperature  in  a 20-p1 
volume containing  either  3 pg of nuclear extract or 2 pl of in vitro 
transcribed/translated protein, 20,000-50,000 cpm of radiolabeled 
probe, 1 pg of poly(d1dC)-poly(d1dC) (Pharmacia LKB, Piscataway, 
NJ) in  a buffer containing 20 mM NaCl, 1 mM DTT, 0.5 mM EDTA, 
10 mM Tris-HC1, pH 8.0, and 2.5 mM MgCI,. Double stranded DNA 
competitor, when used, was added at 100-fold molar excess. Protein- 
DNA complexes were separated from free probe by electrophoresis 
on a 6% nondenaturing polyacrylamide gel in Tris glycine buffer (25 
mM Tris, 190 mM glycine, 1 mM EDTA, pH 8.3). After drying the gel, 
complexes were  visualized by autoradiography. 
Transcription reactions were performed essentially as described 
(39). The plasmids used as templates for in vitro transcription, 
pWToct and pMUToct, are schematically drawn in Fig. 1A and have 
been described in detail (5). They contain wild type DRA X and Y 
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elements  and  either  a wild type or mutant octamer element upstream 
of the bacterial CAT  gene. The TH2A-CAT plasmid contains 248 bp 
of the  rat testis H2A histone promoter upstream of the CAT  gene 
(42) and was kindly provided by Dr. Chi-Bom Chae (University of 
North Carolina, Chapel Hill, NC). The adenovirus major late pro- 
moter-CAT plasmid contains 170 bp of the adenovirus major late 
promoter  upstream of the CAT gene (43), and was kindly provided 
by Dr. A1 Baldwin (University of North Carolina, Chapel Hill, NC). 
Template DNA  was linearized with NcoI, and precipitated  prior to 
use in the reactions. The reaction consisted of template DNA (1.5 
pg), 0.4 mM each ATP, UTP,  and  CTP, 1 mM creatine  phosphate, 
0.14 mM EDTA, 1 p1 of [w3'P]GTP, and  15 pl of extract  in  a  final 
volume of 25 pl. Transcription was  allowed to proceed for 60 min at 
30 "C. The reaction was stopped by adding 275 p1 of stop solution (8 
M urea, 0.5% SDS, 10 mM Tris-HC1, pH 8.0, 10 mM EDTA) plus 
1000 cpm of an internal  standard radiolabeled 494-nucleotide Sp6 
transcript  to detect differences in recovery as previously published 
(39). After extraction with pheno1:chloroform:isoamyl alcohol 
(20201),  the phenol layer was back-extracted with 165 p1 of urea 
extraction buffer (7 M urea, 350 mM NaCl, 10 mM Tris,  pH 8.0, 10 
mM EDTA, 1% SDS) plus 25 pg of tRNA carrier. The  supernatants 
were combined and re-extracted with pheno1:chloroform:isoamyl al- 
cohol and precipitated with 95% ethanol. After washing in 70% 
ethanol, the RNA  was heated at 90 "C for 2 min and electrophoresed 
on a 4% polyacrylamide gel containing  7 M urea. The gel  was then 
autoradiographed. 
Transient Transfection of Plasmid DNA and CAT Assay-Cells 
were transiently  transfected using a Bio-Rad Gene Pulser electropor- 
ation apparatus which  was set a t  200 V and 960 microfarad. Five to 
six X lo6 cells were resuspended in 0.3  ml of complete growth medium 
containing 7.5% heat-inactivated fetal calf serum: RPMI 1640 for 
HSB and Joklik's modified minimal essential medium for HeLa. The 
cell suspension was then placed into  the electroporation chamber, 
followed by addition of DNA (10 pg  of expression plasmid, 10 pg  of 
reporter plasmid), mixing, and application of the voltage pulse. The 
cells were immediately transferred to a 25-cmZ flask containing 10 ml 
of complete growth medium. Approximately 48 h  after  transfection, 
the cells were counted, harvested by centrifugation, washed once with 
phosphate-buffered saline, and resuspended in 50 p1 of  0.25 M Tris- 
HC1, pH 7.6. Cells were then lysed by 3-4 freeze-thaw cycles, and 
cellular debris was  removed  by microcentrifugation for 5 min. After 
heat inactivating the extract at 65 "C for 10 min (44), the same cell 
number equivalents of the resulting extract were assayed for CAT 
activity. The CAT assay was performed as described ( 5 ) ,  except that 
the final concentration of Tris-HC1 was 0.25 M and  the final volume 
of each reaction was 150 pl. The CAT activities were analyzed by 
TLC  and autoradiography. Percent acetylation of chloramphenicol 
was quantified by cutting  out and counting sections of the  TLC plates 
in liquid scintillation fluid. The fold induction of DRA-CAT expres- 
sion by OTF-2 protein was calculated as the percent acetylation 
produced by pWToct  in the presence of pCMV5-OTF-2 divided by 
percent acetylation produced by pWToct  in the presence of pCMV5. 
Additionally, the requirement for an  intact octamer element for OTF- 
2 induction was determined as above except by using the pMUToct 
reporter plasmid. 
RESULTS 
OBPs from B Cells but Not from HeLa Cells Can Partially 
Reconstitute DRA Transcription  in Vitro-To assess whether 
OBPs from B cells which contain  both OTF-1  and OTF-2  or 
OBPs from HeLa cells which only contain OTF-1 could 
reconstitute OTF-depleted DRA gene transcription in vitro, 
we compared the effects of OBPs  enriched from these two cell 
lines on DRA transcription  in an in  vitro run-off transcription 
assay. A plasmid containing the basal DRA promoter up- 
stream of the bacterial chloramphenicol acetyltransferase 
gene was used as a template for transcription (Fig. L4).  A 
schematic depiction of the strategy used for the transcription 
experiments is shown in Fig. 2A. OBPs were enriched by 
eluting HeLa or B cell octamer-binding proteins from an 
octamer element DNA affinity column. In Fig. 2B, a gel 
mobility shift assay (15) was used to  test for the presence and 
specificity of octamer-binding factors  in the material  eluted 
off the column. Shifted complexes corresponding to  OTF-1 
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FIG. 1. A, schematic representation of wild type and mutant MHC 
class I1 DRA reporter plasmids. pWToct  contains 109  bp of the DRA 
promoter placed upstream of the bacterial chloramphenicol acetyl- 
transferase reporter gene. A 66-bp oligonucleotide coding for the DRA 
X, Y, and octamer elements was cloned into the 5'A-43CAT plasmid. 
pMUToct is identical to pWToct except mutant octamer sequence 
replaces wild type octamer sequence. B, schematic representation of 
OTF-2 expression plasmid, pCMV5-OTF-2. Human OTF-2 cDNA 
was cloned into the compatible cloning site of the plasmid pCMV5. 
pCMV5 contains the human cytomegalovirus early promoter, a mul- 
tiple cloning site  linker, and transcription  termination and polyade- 
nylation signals from human growth hormone. 
and OTF-2 were identified based on published profiles from 
ours  and  other laboratories (6, 19, 28, 33). Lanes 1 and 2 are 
whole nuclear extract from Namalwa B cells and HeLa cells, 
respectively. Both cells contain  OTF-1  protein (upper  arrow), 
but only the B cell line  contains  OTF-2  protein (lower  arrow). 
Namalwa B cell OBPs eluted off the octamer element affinity 
matrix contain both OTF-1 and OTF-2 (lane 3 )  which are 
specifically competed with an excess of octamer competitor 
(lane 4 ) ,  but  not with the same amount of a  mutant octamer 
competitor (lane 5 ) .  HeLa cell OBPs eluted off the octamer 
element affinity matrix  contain  OTF-1 (lane 6) and  another 
complex, which can be specifically competed with an excess 
of octamer element competitor (lane 7) ,  but  not with mutant 
octamer competitor (lane 8) .  These OBP-enriched extracts 
were used as  a source of OTF proteins to reconstitute DRA 
gene transcription in a B cell nuclear extract depleted of 
octamer-binding proteins. The extract was depleted of OBPs 
by passage over an octamer element affinity matrix, and the 
depletion of octamer-binding proteins confirmed by  gel mo- 
bility shift assay (data not shown). DRA in  vitro transcription 
using nondepleted B cell extracts  as  a source of transcription 
factors resulted in the correct 595-nucleotide run-off tran- 
script (left  arrow) (Fig. 2C, lanes 1 and 4 ) ,  whereas octamer- 
depleted B cell extracts produced no DRA transcription (lanes 
2 and 5 ) .  It is critical that any differences in  OTF-1  and  OTF- 
2 activity would not be due to different amounts of these 
proteins used for reconstitution, therefore equivalent binding 
activity was determined by titration of these OBP-enriched 
fractions  in  a gel mobility shift assay (data  not shown). B cell 
and HeLa cell OBPs  containing similar amounts of OTF-1 
binding activity were added to the depleted transcription 
reaction (see Fig. 2 A ) .  B cell OBPs could partially  reconstitute 
transcription (lane 3 ) ,  whereas HeLa cell OBPs could not 
(lane 6). The  partial reconstitution with B cell OBPs averaged 
35% as quantitated relative to the level of internal 494- 
nucleotide standard (arrowhead) in three separate experi- 
ments  as  determined by densitometric scanning of autoradi- 
ographs. When the same type of experiment was done using 
a plasmid containing  a  mutated octamer element as  a  tran- 
scription  template, no effect of B cell OBPs was seen (data 
not  shown). As a control to demonstrate that  the HeLa cell 
OBPs were functional, we determined that HeLa  OBPs could 
reconstitute octamer-depleted transcription from the TH2A 
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FIG. 2. A, flow diagram of the strategy used for DRA in uitro 
transcription reconstitution  experiments. B cell nuclear extract was 
depleted of octamer-binding proteins by passage over an octamer 
DNA affinity column. This octamer-binding  protein-depleted extract 
did  not  support DRA run-off transcription (see C). Octamer-binding 
proteins enriched from B cells (which contain OTF-2 and  OTF-1) or 
from HeLa cells (which contain  OTF-1) were assessed for their ability 
to  reconstitute DRA gene transcription. R, gel mobility shift of 
octamer-binding proteins enriched from B cell and HeLa cell nuclear 
extracts. B cell (lune 1 )  or HeLa cell (lune 2 )  nuclear  extracts, and 
octamer-binding  proteins  enriched from B cells (lanes 3-5) or octa- 
mer-binding proteins enriched from HeLa cells (lunes 6-8) were 
incubated with a radiolabeled octamer DNA probe in  the presence of 
no competitor (lunes 1-3 and 6 ) ,  wild type  octamer  competitor (lunes 
4 and 7 ) ,  or mutant octamer  competitor (lanes 5 and 8) .  The resulting 
complexes were electrophoresed on  a 6% nondenaturing Tris glycine 
polyacrylamide gel. C, functional  analysis of B cell or HeLa cell OBPs 
in DRA in uitro transcription. DRA in uitro transcription using B 
cell nuclear extracts (lunes I and 4 )  or B cell nuclear extracts depleted 
of octamer-binding  proteins (lanes 2, 3, 5,  and 6 ) .  B cell OBPs were 
added to lune 3, HeLa cell OBPs were added to lune 6, and no OBPs 
were added to lunes 2 and 5.  The correct DRA run-off transcription 
product (left arrow) is indicated. As a control for HeLa cell OBP 
gene (Fig. 2C, lunes 7 and 8). These  experiments  demonstrate 
that B cell-derived OBPs  can  partially  reconstitute  octamer- 
depleted DRA gene transcription, whereas HeLa cell-derived 
OBPs cannot. Additionally, this effect is dependent on an 
intact  octamer element. 
Cloned OTF-2  Protein Positively Affects DRA Gene Trun- 
scription in Vitro-Octamer-binding proteins enriched from 
B cells were able  to  partially  reconstitute octamer-depleted 
DRA transcription,  in  contrast  to  octamer-binding  proteins 
enriched from HeLa cells. Since B cells make OTF-2 protein 
and  HeLa cells do  not,  this suggests that  OTF-2 was respon- 
sible for the reconstitution of octamer-depleted DRA gene 
transcription  that we had observed. We tested  this directly 
using  cloned OTF-2  protein.  For  these  experiments, a  plasmid 
coding  for human  OTF-2 was  utilized as a  source of recom- 
binant OTF-2 protein. OTF-2 protein was transcribed and 
translated  in vitro from this plasmid in  the  sense  orientation, 
resulting  in  the  correct  OTF-2  band  as assessed  by gel mobility 
shift  assay (Fig. 3A, lane 2). As a  comparison,  nuclear extracts 
from the B cell line  Namalwa (lune 1 ) gave the expected OTF- 
1 (upper  arrow)  and  OTF-2 (lower arrow) shifted  bands. The 
recombinant  OTF-2  shifted  band was specific since it could 
be competed with an excess of wild type octamer element 
(lune 3 )  but was not competed with  the  same molar amount 
of mutant  octamer  element (lune 4). Protein  transcribed  and 
translated from the  same plasmid, but  in  the  antisense ori- 
entation did not  result  in a specific OTF-2  protein (lune 5). 
This  antisense  protein was used as a control for the cloned 
OTF-2  protein  in  the DRA transcription experiments. The 
extra  bands  in  the  sense  and  antisense  recombinant OTF-2 
lanes (lunes 2 and 5; arrowheads)  are specific octamer-binding 
proteins produced by the  rabbit reticulocyte  lysate  (compare 
lunes 3 and 4 ) .  HeLa cells do  not  contain  OTF-2  protein (see 
Fig. 2B)  and were used as a source of general transcription 
factors. We (5) have previously reported  that  HeLa  extracts 
can only minimally support transcription from the DRA 
promoter. Cloned OTF-2 protein added to HeLa nuclear 
extracts allows for increased DRA gene transcription (Fig. 
3B, lune 2, left arrow) over a control  extract  to which antisense 
OTF-2  has been added (lune 1 ). The arrowhead  corresponds 
to the 494-nucleotide internal standard. When a plasmid 
containing a mutated  octamer  element is used as a template 
for transcription,  OTF-2  protein in the sense or  in  the  anti- 
sense  direction  has  no effect (data  not shown). As another 
control for  specificity, we examined the effect of recombinant 
OTF-2  protein  on  transcription from the adenovirus major 
late  promoter  (right  arrow), which  does not  contain  an  octa- 
mer  element  in  its  promoter.  Recombinant  OTF-2  protein i
the sense or in the antisense direction had no effect on 
adenovirus major late  promoter  transcription (lunes 3 and 4) .  
Thus,  OTF-2 plays  a  positive role in DRA gene transcription. 
This effect is also dependent  on  an  intact  octamer element. 
I n  Vivo Role of Recombinant OTF-2  Protein  on DRA Gene 
Transcription-To further  address  the effect of OTF-2  pro- 
tein expression on DRA gene transcription,  an  OTF-2 expres- 
sion plasmid, pCMV5-OTF-2 (Fig. lB), was co-transfected 
into  the  human T cell line HSB  or  into  HeLa cells along  with 
DRA-CAT  reporter  plasmids  pWToct  or  pMUToct.  HSB  and 
HeLa cells lack  endogenous OTF-2  protein  and DRA expres- 
sion is negligible (33). The reporter plasmids contain wild 
function, in uitro transcription from the THPACAT plasmid was 
analyzed using HeLa cell extracts depleted of octamer-binding pro- 
teins (lanes 7 and 8 )  without (lune 7 )  or with (lune 8 )  added HeLa 
cell OBPs. The correct THPA run-off transcription product (right 
arrow) is  indicated. The arrowhead indicates the 494-nucleotide in- 
ternal  standard included in all reactions. 
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type  or  mutant  octamer  elements  in  the  context of 109 bp of 
DRA  promoter sequence  (see Fig. lA ). As a control for the 
OTF-2 expression  plasmid, the  same xpression plasmid  with- 
out  OTF-2 sequence  was  used  (pCMV5). The effect of OTF- 
2 protein on DRA promoter function was determined by 
comparing  the levels of CAT enzyme  produced by pWToct  in 
the presence of the  OTF-2  or  the  control CMV expression 
plasmids.  A representative  result of the  transient  transfection 
analysis using HSB cells (Fig. 4) is shown.  DRA-CAT expres- 
sion was induced 2.6-fold by CMV-OTF-2  in  HSB cells (com- 
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FIG. 3. A ,  gel mobility shift  analysis of in vitro transcribed/trans- 
lated  human OTF-2. B cell nuclear  extract (lane I )  or recombinant 
OTF-2  protein  obtained  from  OTF-2  translated  in  the  sense  orien- 
tation (rOTF-2-s; lanes 2-4) or in  the  antisense  orientation (as; lane 
-5) were incubated with a radiolabeled octamer DNA probe in the 
absence of competitor (lunes I ,  2, and5),  wild type  octamer  competitor 
(lane 3) ,  or mutant  octamer  competitor (lane 4 ) .  OTF-1  and  OTF-2 
shifted complexes are indicated. Arrowheads indicate  octamer-bind- 
ing  proteins produced by the  rabbit reticulocyte  lysate. The  protein- 
DNA  complexes were electrophoresed on a 6% nondenaturing  Tris 
glycine polyacrylamide gel. B, functional analysis of recombinant 
human  OTF-2  protein  in DRA in vitro transcription. I n  vitro tran- 
scription from the DRA promoter (lanes I and 2) or the MLP 
promoter ( lams  3 and 4 )  using HeLa nuclear extracts to supply 
general transcription  factors  plus  either  recombinant  OTF-2  protein 
obtained from OTF-2  translated  in  the  sense  orientation (s; lanes 2 
and 4 )  or in the  antisense  orientation (as; lanes I and 3).  The correct 
DRA  run-off transcription  product (left  arrow) and  the  correct  MLP 
run-off product (right  arrow) are indicated. The 494-nucleotide inter- 
nal  standard (arrowhead) is included in  all reactions. 
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FIG. 4. In uiuo role of recombinant OTF-2 protein on DRA 
gene  transcription. Assay of CAT activity in  extracts from HSB 
(lanes 2-4) cells transiently  co-transfected with either  DRA-WToct 
(lanes I and 2 )  or DRA-MUToct (lanes 3 and 4 )  reporter  plasmids 
and pCMV5 (lanes 1 and 3 )  or pCMV5-OTF-2 (lunes 2 and 4 )  
expression  plasmids. Ethyl  acetate-extracted  material was separated 
by thin layer chromatography  and subjected to  autoradiography. 
pare lanes 2 and 1 ). We  have  repeated the  experiments using 
HSB cells 4 times  and we have consistently observed a 2-3- 
fold induction of CAT expression by OTF-2. To determine if 
the effect of OTF-2  is  dependent  on  the  octamer  element, a 
reporter plasmid containing a mutant  octamer  element, 
pMUToct, was used  for similar  experiments (Fig. 4, lanes 3 
and 4 ) .  OTF-2  had  little effect on  CAT expression from the 
pMUToct plasmid, demonstrating  that  OTF-2 induction of 
DRA-CAT expression requires an intact octamer element. 
This effect was also observed when the  similar  experiment 
was  performed  using HeLa cells (data  not shown). 
DISCUSSION 
Transcriptional regulation is  an  important mechanism for 
the control of class I1 MHC gene expression. Several cis- 
acting  elements  in  the  promoters of MHC class I1 genes have 
been defined that mediate this  transcriptional control. The 
octamer element, ATTTGCAT, is one of the cis elements 
defined that  is necessary for DRA gene transcription in B 
cells, but  not  in  non-B cells that express  class I1 molecules 
(6).  This conclusion was reached  because  mutagenesis of the 
octamer  element  in DRA greatly  diminished gene expression 
in B cell lines but not in DR' non-B cell lines. We had 
previously demonstrated by gel mobility shift  assays  that two 
proteins  bind  to  the DRA octamer element, one B cell-specific 
and  the  other  not (33). These were thought  to be the octamer- 
binding proteins OTF-2 and OTF-1, respectively. Although 
both  OTF-2  and  OTF-1 were capable of binding to the DRA 
promoter in uitro, it  was not known whether  these octamer- 
binding  proteins functionally contributed  to DRA gene tran- 
scription.  In  this  report, we demonstrated  the role of OTF-2 
protein  in DRA gene transcription. 
OTF-2  protein  function was assessed in  both a cell-free i n  
uitro transcription  system  and by i n  vivo transient  transfec- 
tion studies. Similar conclusions were obtained using both of 
these approaches. Octamer-binding  proteins enriched from B 
cells which contain OTF-2 could partially restore octamer- 
depleted DRA transcription in uitro, whereas those from HeLa 
cells which do  not  contain  OTF-2  protein  had  no effect (Fig. 
2). Furthermore, recombinant human OTF-2 protein could 
potentiate DRA gene transcription,  but  to a lesser extent  than 
enriched cellular OTF-2 (Fig. 3). This  result  is  consistent with 
data from other  laboratories  that suggests a role for an addi- 
tional B cell factor  in Ig gene regulation (28-30). Perhaps  this 
same or another B cell factor is also required for optimal 
MHC DRA gene transcription. Our i n  uiuo studies demon- 
strated  that  OTF-2  protein  enhanced DRA gene transcription 
2-3-fold, and  that  this effect  requires an  intact  octamer ele- 
ment (Fig. 4). Together  these  results  demonstrate a role for 
the  OTF-2  protein in DRA gene transcription. 
Although the effect of OTF-2 did not seem very dramatic, 
contributing  about 2-3-fold enhancement of DRA transcrip- 
tion,  it was very reproducible and  the  extent of OTF-2  con- 
tribution was similar using  two very different  methods, i.e. in 
uitro cell-free transcription  and i n  vivo transient transfection. 
This level of effect was not unexpected  since protein binding 
to  the  octamer  element was thought  to  act in  concert  with 
DNA-protein  interactions a t  other known regulatory  elements 
of the DRA gene, including the  W, X, and Y elements (4). 
We have already previously demonstrated a positive func- 
tional role for one Y element-binding  protein  YEBP, in DRA 
gene transcription in B cells (39). I t  will be informative to 
study  the effects of all of the  MHC class I1 promoter-binding 
proteins individually as well as in combination with each 
other  to discern their roles in  transcription. 
In our studies, the OTF-1 enriched preparation did not 
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affect DRA  gene transcription (Fig. 2). This is not due to  the 
inactivity of OTF-1 in these  preparations because it enhanced 
transcription of the control TH2A promoter. At first glance, 
this seems to be in contrast to other studies where either 
OTF-1 or OTF-2 could positively regulate expression of the 
B cell-specific IgFgene (28-30,45). Octamer-enriched extracts 
used for our reconstitution experiments contained similar 
levels of OTF-1 binding activity; therefore the differential 
ability of these two fractions to affect DRA  gene transcription 
could not be due simply to differences in the amounts of 
octamer-binding proteins added. It is more likely that since 
the context of the octamer element in  the DRA promoter is 
different from that  in  the Ig promoter, the proteins that bind 
to this element function differently in  the two genes.  Addi- 
tionally, since octamer-enriched fractions from B cells were 
able to potentiate DRA gene transcription more than recom- 
binant OTF-2 protein alone, another factor, potentially an 
additional B cell-specific factor similar to  the one that  acts in 
conjunction with OTF-2  in Ig transcription (29, 30), is also 
required for optimal MHC class I1 DRA  gene transcription. 
Although the octamer element and  the OTF-2  protein play 
a role in MHC class I1 DRA  gene transcription,  other  human 
MHC class I1 genes do not contain an obvious octamer 
element in their promoters. Interestingly, the DRA homo- 
logues in other primates, including old and new world mon- 
keys, also contain octamer elements in similar locations in 
their promoter regions (46). Whether  this suggests that  the 
octamer-binding protein  OTF-2 only affects transcription of 
the DRA gene (and  potentially  its  primate homologues) but 
not other MHC class I1 genes, or whether the octamer-binding 
protein  can  bind to other DNA sequences in  the promoters of 
these genes remains to be determined. The octamer-binding 
proteins have, however, been shown to bind to DNA sequences 
other  than  the canonical ATTTGCAT octamer element in- 
cluding the TAATGARAT (R = purine) sequence upstream 
of the herpes simplex virus immediate-early genes (47), the 
AAGAATAAATTAGA site in the Ay-globin gene promoter 
(48), and the heptamer element CTCATGA in  the Ig heavy 
chain promoter (49, 50). On the  other hand, if OTF-2  is only 
able to regulate transcription from the DRA MHC class I1 
promoter, this could explain a possible mechanism for the 
higher levels of DR protein relative to  DP or DQ proteins 
that  are normally found on class I1 expressing cells (51). 
In conclusion, this is the first demonstration that the 
lymphoid-specific octamer-binding protein, OTF-2, can posi- 
tively regulate expression of the MHC class I1 gene, DRA. 
Using both affinity-enriched protein fractions and in vitro 
translated  OTF-2  protein in an in vitro transcription system, 
in addition to  an in uiuo approach, our  results established a 
role for OTF-2 in DRA transcription.  Experiments  are ongo- 
ing  to determine the role of other  proteins which may interact 
with OTF-2 in DRA gene expression. 
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